PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. Electronic address: marc.pawlitzki@ukmuenster.de.\', \'Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany.\', \'Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.\', \'Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.\', \'Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. Electronic address: sven.meuth@ukmuenster.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(20)30197-310.1016/j.ebiom.2020.102822
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 32535547
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
?:title
  • Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all